- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 5, 2025 | 47.14M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $19.04M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $24.87M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $31.23M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $218.24M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $209.36M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $114.38M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $110.45M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $196.19M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $161.68M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $170.24M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $164.21M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $414.5M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $371.19M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $363.97M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 46.96M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 48.9M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $3.08M |
| Capex | Q3 2025 · Mar 31, 2024 | $7.15M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $16M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.02 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.06 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.06 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $9.99M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $29.99M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$703K |
| Net Income | Q3 2025 · Mar 31, 2024 | $2.9M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$906K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $4.42M |
| Revenue | Q3 2025 · Mar 31, 2024 | $184.56M |
| Revenue | Q3 2025 · Mar 31, 2024 | $596.44M |